Fourteen Cents

"What exactly do I need to keep out?" I asked.

Grant took a step back from the table.

"An unverified suspicion. You could create a panic over a routine sourcing decision."

"So there was a sourcing decision. Which adhesive did you authorize?"

Evelyn stood. "This conversation is finished."

"Daniel, did you hear that?"

"I did," he said from my phone. "Please leave the room, Maya. We'll request preservation of the relevant records immediately."

Grant moved away from the door.

I walked out before my anger could make the choice for me.

In the elevator, I called Tessa Boone.

She answered in a whisper.

"Please tell me you're still in the building."

"I'm heading downstairs. Did procurement change the binding adhesive in the Argent sample build?"

A pause.

"I objected to that change."

My hand tightened around the phone.

"When?"

"Six weeks ago. I thought you knew."

By the time I reached the lobby, Daniel had arranged a call with Adrian. He told me to go somewhere private, stay out of company systems after my termination, and let the board authorize any technical work they wanted from me.

I sat in my car with my bag on the passenger seat.

My hands finally started shaking.

I hadn't cried in the boardroom. Now I couldn't make my thumb press the right contact.

Owen answered on the third attempt.

"They fired me," I said.

He didn't tell me to calm down.

"Where are you?"

"The garage."

"Stay there until you can drive. I'll come if you want."

I stared through the windshield at a concrete column.

"They put somebody else's name on my work. Then they offered me money to sign it away."

"Did you sign anything?"

"No."

"Then you still have your choice. Take a breath. I'm here."

I stayed on the line until I could feel my fingers again.

That afternoon, the board's outside counsel contacted Daniel. Judith Rowan, Blackidge's chairwoman, was returning to Detroit. She authorized records preservation and asked me to assist with a limited technical review, under a written agreement Daniel approved.

My employment status remained disputed. My access remained restricted. For once, somebody wrote down what they were asking me to do before asking me to do it.

Argent's engineers were already testing the retained sample modules at their Chicago facility. Adrian arranged for their technical lead to speak to me directly.

She shared two plots, the build manifest, and photographs of the adhesive packaging.

I knew the product code before she finished introducing herself.

"That isn't the adhesive in my approved specification," I said.

"The manifest describes it as equivalent."

"Equivalent under which test conditions?"

We spent the next hour comparing the qualification requirements with the tests procurement had accepted. The replacement performed adequately in ordinary conditions. The missing tests involved heat, vibration, aging, and repeated fast charging in combination.

The shield worked by maintaining separation when a cell failed. An adhesive that softened or separated at the wrong time could undermine that barrier.

The exact behavior still needed testing. The gap in validation was already clear.

"Could this explain the early degradation?" the engineer asked.

"Yes. We need to isolate the variables and verify it. Until then, nobody should call the substitution safe."

She nodded. "We're holding the samples."

Tessa met me in a conference room outside the executive suite an hour later. An outside investigator was present to receive her records.

She carried a black binder with a cracked spine.

"I kept the exception reports in the compliance archive," she said. "They stopped routing them to you."

I'd known Tessa for four years. She always arrived at meetings with a pen clipped inside her notebook. People spoke over her until they needed a signature.

Today, she couldn't get the cap off.

I took the pen, uncapped it, and handed it back.

"Start with the first warning," I said.

She opened the binder.

The chronology was ugly and simple.

A supplier had proposed a cheaper product. Grant had approved the change for the acquisition sample run without completing our qualification process. Tessa had flagged the missing testing. An executive override had allowed the build to proceed.

The projected saving was fourteen cents per cell.

I read the number twice.

Grant's department had included the improvement in its margin forecast. My name remained on the technical specification attached to the pack, although I hadn't approved the deviation.

"They left my approval on it?"

Tessa pointed to the exception sheet.

"Your original design approval. They treated the substitution as an administrative change."

I sat back.

If the product failed, the clean specification would point to me. The decision that weakened it lived in a different folder.

The investigator asked Tessa to identify where the originals were kept. She supplied the archive location and the associated messages so the team could collect them independently.

Then she turned to a marked page.

"Read the last paragraph."

It was an email from Evelyn to Grant, copied to a procurement manager.

A delay, Evelyn wrote, would threaten the closing window. The company should proceed with the current build and address any remaining performance concerns after the acquisition funded the next development cycle.

Tessa's warning was attached beneath it.

She'd asked whether production should be held pending validation.

The answer had been no.

I pressed my palms against the table.

For weeks I'd wondered whether I was becoming unreasonable. Whether exhaustion had made every missing invitation feel deliberate. Whether asking one more question was worth another conversation about my attitude.

Here was the answer in Evelyn's own email.

She'd known enough to stop.

She'd decided to close first.

Judith called while we were still with the investigator.

"Argent has raised a technical concern," she said. "I need to know how serious it is."

"Serious enough to stop the affected builds and verify every batch that used the substitute."

"Can we resolve it with a commercial concession?"

I looked at the fourteen-cent figure.

"A lower price won't change the adhesive."

She went quiet.

"Tessa has the override records," I continued. "Your investigators are collecting them. I want the affected material quarantined while the engineers establish the scope."

"Send me the recommendation."

"I'll send it to everyone who has to act on it."

An hour later, written confirmation arrived. The affected sample builds and material lots were on hold. No associated shipment would leave pending review.

I showed Tessa the message.

She read it once, then covered her mouth with her hand.

For the first time that day, something had stopped because an engineer said it should.